Literature DB >> 26662070

Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.

Amal S El-Shal1, Haidy E Zidan1, Nearmeen M Rashad2, Ahmed M Abdelaziz3, Mervat M Harira4.   

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine-metabolic disorders; however, its pathophysiology is still unclear. Certain polymorphisms of luteinizing hormone beta-subunit (LHβ) and LH/choriogonadotrophin receptor (LHCGR) genes may lead to changes in the bioactivity of this hormone. We aimed to investigate possible associations between polymorphisms in the LHβ and LHCGR genes and PCOS among Egyptian women. We also aimed to shed light on the impact of these polymorphisms on LH level, hormonal, and metabolic features of PCOS. A case-control study included unrelated 210 patients with PCOS and 200 healthy controls, and they were stratified according to their body mass index into two subgroups: lean and obese. Polymorphisms of LHβ G1502A and LHCGR [G935A, and ins18LQ] genes were genotyped using polymerase chain reaction-restriction fragment length polymorphism. Our results revealed that LHβ G1052A GA genotype and A allele, LHCGR G935A GA, AA genotypes, or A allele were significantly associated with PCOS risk, while the LHCGR ins18LQ polymorphism was not. Additionally, there is a synergism between LHβ G1052A minor A and minor A allele of LHCGR G935A or minor ins allele of LHCGR ins18LQ and susceptibility to PCOS. When we stratified PCOS women or controls into obese and lean subjects, we found that LHβ G1502A GA genotype and A allele being more frequent in the obese group when compared with lean patients with PCOS [The odds ratio and 95% confidence interval were 5.6 (1.30-24.56) and 5.15 (1.21-21.90), respectively, P = 0.01, for each group.] These results suggested that LHβ G1052A and LHCGR G935A genes polymorphisms are associated with increased risk of PCOS in Egyptian women especially in obese cases. There was a synergism between LHβ G1052A minor A allele and of LHCGR G935A minor A or minor ins alleles of LHCGR ins18LQ and PCOS risk.
© 2015 IUBMB Life, 68(1):23-36, 2016. © 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  Egyptian women; luteinizing hormone; obesity; polycystic ovary syndrome; polymerase chain reaction

Mesh:

Substances:

Year:  2015        PMID: 26662070     DOI: 10.1002/iub.1457

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  7 in total

Review 1.  The role of miRNAs in polycystic ovary syndrome with insulin resistance.

Authors:  Yingliu Luo; Chenchen Cui; Xiao Han; Qian Wang; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

2.  Mutational Landscape Screening Through Comprehensive In Silico Analysis for Polycystic Ovarian Syndrome-Related Genes.

Authors:  Shrinjana Dhar; Saptarshi Mridha; Pritha Bhattacharjee
Journal:  Reprod Sci       Date:  2021-10-25       Impact factor: 3.060

3.  ERBB4 Confers Risk for Polycystic Ovary Syndrome in Han Chinese.

Authors:  Yingqian Peng; Wei Zhang; Ping Yang; Ye Tian; Shizhen Su; Changming Zhang; Zi-Jiang Chen; Han Zhao
Journal:  Sci Rep       Date:  2017-02-14       Impact factor: 4.379

4.  Association of miRNA - 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome.

Authors:  Nearmeen M Rashad; Marwa Abdel-Monem Ateya; Yasser S Saraya; Walid Mohamed Elnagar; Khaled Fathy Helal; Mohamed El-Bakry Lashin; Amr Ahmed Abdelrhman; Ayman E Alil; Mohammed S Yousef
Journal:  J Ovarian Res       Date:  2019-05-07       Impact factor: 4.234

Review 5.  Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome.

Authors:  Zahra Shaaban; Arezoo Khoradmehr; Mohammad Reza Jafarzadeh Shirazi; Amin Tamadon
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

6.  Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome.

Authors:  Nearmeen M Rashad; Amal S El-Shal; Hala G Abomandour; Amr Mostafa Kamel Aboelfath; Mohamed El Sayed Rafeek; Mohammad Samir Badr; Ayman E Ali; Mohammed S Yousef; Maha Abdelhamid Fathy; Mustafa Taha Abdelfattah Sharaf El Din
Journal:  J Ovarian Res       Date:  2019-10-19       Impact factor: 4.234

7.  Role of Single Nucleotide Variants in FSHR, GNRHR, ESR2 and LHCGR Genes in Adolescents with Polycystic Ovary Syndrome.

Authors:  Lasma Lidaka; Laine Bekere; Adele Rota; Jekaterina Isakova; Gunta Lazdane; Anda Kivite-Urtane; Iveta Dzivite-Krisane; Inga Kempa; Zane Dobele; Linda Gailite
Journal:  Diagnostics (Basel)       Date:  2021-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.